While elevated GH did not accelerate growth of implanted melanoma tumors in vivo, cellular analyses showed that elevated GH activates oncogenic signaling, upregulates the intrinsic capacity of the tumor for drug clearance and metastatic features (Figure 5). The gene discussed is GH1; the disease is neoplasm.